Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024

Rhea-AI Summary

Talphera Inc. (Nasdaq: TLPH), a specialty pharmaceutical company, has announced it will release its second quarter 2024 financial results after market close on Wednesday, August 14, 2024. The company will host a live webcast and conference call at 4:30 p.m. Eastern Standard Time/1:30 p.m. Pacific Standard Time to discuss the results and provide a business update.

Investors can access the webcast through the company's website or join the conference call by dialing 1-800-836-8184 (North America) or 1-646-357-8785 (international) using the conference ID 28132. The webcast will include a slide presentation, and a replay will be available on Talphera's website for 90 days following the event.

SAN MATEO, Calif., Aug. 5, 2024 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will release second quarter 2024 financial results after market close on Wednesday, August 14, 2024, then host a live webcast and conference call at 4:30 p.m. Eastern Standard Time/1:30 p.m. Pacific Standard Time to discuss the results and provide an update on the Company's business.

Webcast Information

The webcast can be accessed here or by visiting the Investors section of the Company's website at www.talphera.com and clicking on the webcast link posted within Investors/News & Events/Upcoming Events section. The webcast will include a slide presentation and a replay will be available on the Talphera website for 90 days following the event.

Conference Call Information

Investors who wish to participate in the conference call may do so by dialing 1-800-836-8184 for North American callers, or 1-646-357-8785 (toll applies) for international callers outside of Canada. The conference ID is 28132.

About Talphera, Inc.

Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA). Talphera is also developing two pre-filled syringes in-licensed from its partner Aguettant: Fedsyra™, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.

This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/talphera-to-host-second-quarter-2024-financial-results-and-corporate-update-call-and-webcast-on-wednesday-august-14-2024-302214600.html

SOURCE Talphera, Inc.

FAQ

When will Talphera (TLPH) release its Q2 2024 financial results?

Talphera (TLPH) will release its second quarter 2024 financial results after market close on Wednesday, August 14, 2024.

What time is Talphera's (TLPH) Q2 2024 earnings call scheduled for?

Talphera's (TLPH) Q2 2024 earnings call is scheduled for 4:30 p.m. Eastern Standard Time/1:30 p.m. Pacific Standard Time on Wednesday, August 14, 2024.

How can investors access Talphera's (TLPH) Q2 2024 earnings webcast?

Investors can access Talphera's (TLPH) Q2 2024 earnings webcast through the company's website at www.talphera.com, in the Investors section under Upcoming Events.

What are the conference call details for Talphera's (TLPH) Q2 2024 earnings?

For Talphera's (TLPH) Q2 2024 earnings call, investors can dial 1-800-836-8184 (North America) or 1-646-357-8785 (international) using the conference ID 28132.